Search - tctmd.com

Displaying 121 - 140 of 254

Sort: Relevancy | Date

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

Presentation TCT 2017

How to Manage Conduction Abnormalities and Pacemaker Implantation (temporary and permanent) After TAVR

Presenter: Torsten P. Vahl, Mathew Williams, Steven J. Yakubov

November 01, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

A Case of TAVR, Left Main PCI and Permanent Pacemaker Implantation in a Nonagenarian

Presenter: Wojtek Wojakowski, Gautam Naik

October 30, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Conference News PCR London Valves 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Shelley Wood

September 26, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Daily News

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Caitlin E. Cox

April 21, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Presentation

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

April 12, 2017

Advertisement

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

How to Manage Conduction Abnormalities and Pacemaker Implantation (temporary and permanent) After TAVR

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

A Case of TAVR, Left Main PCI and Permanent Pacemaker Implantation in a Nonagenarian

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content